Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Alzheimers Dement. 2020 Jan 4;16(3):572–580. doi: 10.1016/j.jalz.2019.09.080

Table 1.

Clinical Characteristics of the Study Sample

Characteristic Entire cohort (N=553) Apolipoprotein ε4 status
ε4 (N=106) No ε4 (N=447)
Age, M ± SD 76.7 ± 5.2 75.8 ± 4.3 77.0 ± 5.3
Female, n (%) 324 (58) 63 (58) 261 (58)
Surgery type, n (%)
 Orthopedic 451 (81) 81 (75) 370 (83)
 Vascular 35 (6) 7 (6) 28 (6)
 Colectomy 71 (13) 20 (19) 51 (11)
Preoperative GCP*, M ± SD 57.6 ± 7.3 57.6 ± 7.9 57.6 ± 7.1
CRP postop day 2**, M ± SD 181.9 ± 81.2 167.5 ± 85.7 185.3 ± 79.8
Major postop complication, n (%) 47 (8) 8 (7) 39 (9)
Delirium incidence, n (%) 132 (24) 26 (25) 106 (24)
Delirium severity***, M ± SD 9.3 ± 11.4 9.0 ± 11.2 9.3 ± 11.5
Delirium days, n (%)
 0 421 (76) 80 (75) 341 (76)
 1 82 (15) 17 (16) 65 (14)
 2 28 (5) 6 (6) 22 (5)
 3+ 22 (4) 3 (3) 19 (5)

abbreviations: CRP=C-reactive protein, GCP =general cognitive performance, M=mean, SD=standard deviation

Apolipoprotein E ε4 carriers defined as ε4ε4 and ε4ε3.

*

Composite measure of neuropsychological measures reflecting cognitive domains vulnerable to delirium, population mean 50 ± 10, externally scaled to the Health and Retirement Survey of Aging, Demographics, and Memory Study [61]

**

See Supplementary Figure 2 for distribution of CRP measured preoperatively and on POD2 by Apolipoprotein E ε4 carrier status

***

Defined as the sum of Confusion Assessment Method (CAM)-S scores, which sums the severity ratings of 10 CAM features (range 0-19, 19 most severe).